Cargando…

A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons

BACKGROUND: Processing of the amyloid-β protein precursor (AβPP) is neurophysiologically important due to the resulting fragments that regulate synapse biology, as well as potentially harmful due to generation of the 42 amino acid long amyloid β-peptide (Aβ(42)), which is a key player in Alzheimer’s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yang, Gao, Yang, Winblad, Bengt, Tjernberg, Lars O., Schedin-Weiss, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543249/ https://www.ncbi.nlm.nih.gov/pubmed/34366358 http://dx.doi.org/10.3233/JAD-215008

Ejemplares similares

Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons
por: Gao, Yang, et al.
Publicado: (2021)

Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse
por: Schedin-Weiss, Sophia, et al.
Publicado: (2016)

Monoamine oxidase B is associated with γ-secretase in cultured neurons and in brain
por: Weiss, Sophia Schedin, et al.
Publicado: (2013)

Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses
por: Yu, Yang, et al.
Publicado: (2018)

Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein
por: Lin, Tong, et al.
Publicado: (2022)

Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
por: Sandebring-Matton, Anna, et al.
Publicado: (2021)

Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
por: Schedin-Weiss, Sophia, et al.
Publicado: (2017)

Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ(42)-Induced Pathways to Alzheimer’s Disease Pathology
por: Schedin-Weiss, Sophia, et al.
Publicado: (2020)

Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
por: Axenhus, Michael, et al.
Publicado: (2022)

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
por: Schedin‐Weiss, Sophia, et al.
Publicado: (2020)

The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease
por: Gaunitz, Stefan, et al.
Publicado: (2020)

Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
por: Lin, Tong, et al.
Publicado: (2021)

What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
por: Gaunitz, Stefan, et al.
Publicado: (2021)

Visualizing Active Enzyme Complexes Using a Photoreactive Inhibitor for Proximity Ligation – Application on γ-Secretase
por: Schedin-Weiss, Sophia, et al.
Publicado: (2013)

Dual Bioorthogonal Labeling of the Amyloid-β Protein Precursor Facilitates Simultaneous Visualization of the Protein and Its Cleavage Products
por: van Husen, Lea S., et al.
Publicado: (2019)

Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden
por: Axenhus, Michael, et al.
Publicado: (2021)

Analysis of microdissected neurons by (18)O mass spectrometry reveals altered protein expression in Alzheimer's disease
por: Hashimoto, Masakazu, et al.
Publicado: (2012)

The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
por: Haytural, Hazal, et al.
Publicado: (2021)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer’s Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis
por: Tiiman, Ann, et al.
Publicado: (2019)

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
por: Sandberg, Anders, et al.
Publicado: (2022)

Distinctive alteration of presynaptic proteins in the outer molecular layer of the dentate gyrus in Alzheimer’s disease
por: Haytural, Hazal, et al.
Publicado: (2021)

Protective Effects of Wogonin against Alzheimer's Disease by Inhibition of Amyloidogenic Pathway
por: Huang, Ding-Siang, et al.
Publicado: (2017)

γ-Secretase Dependent Production of Intracellular Domains Is Reduced in Adult Compared to Embryonic Rat Brain Membranes
por: Frånberg, Jenny, et al.
Publicado: (2010)

Engineered Human Induced Pluripotent Cells Enable Genetic Code Expansion in Brain Organoids
por: van Husen, Lea S., et al.
Publicado: (2021)

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
por: Zhao, Jing, et al.
Publicado: (2020)

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
por: Bonito‐Oliva, Alessandra, et al.
Publicado: (2019)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Visualization of APP and BACE-1 approximation in neurons: new insights into the amyloidogenic pathway
por: Das, Utpal, et al.
Publicado: (2015)

Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
por: Waragai, Masaaki, et al.
Publicado: (2020)

Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
por: He, Hongwen, et al.
Publicado: (2010)

Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2020)

Resolving the soluble-to-toxic transformation of amyloidogenic proteins: A method to assess intervention by small-molecules
por: Ahlawat, Jyoti, et al.
Publicado: (2023)

The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease
por: Haytural, Hazal, et al.
Publicado: (2020)

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u54f8daa41ghsd69pjgbiief3j